The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Role for miR-204 in human pulmonary arterial hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) is characterized by enhanced proliferation and reduced apoptosis of pulmonary artery smooth muscle cells (PASMCs). Because microRNAs have been recently implicated in the regulation of cell proliferation and apoptosis, we hypothesized that these regulatory molecules might be implicated in the etiology of PAH. In this study, we show that miR-204 expression in PASMCs is down-regulated in both human and rodent PAH. miR-204 down-regulation correlates with PAH severity and accounts for the proliferative and antiapoptotic phenotypes of PAH-PASMCs. STAT3 activation suppresses miR-204 expression, and miR-204 directly targets SHP2 expression, thereby SHP2 up-regulation, by miR-204 down-regulation, activates the Src kinase and nuclear factor of activated T cells (NFAT). STAT3 also directly induces NFATc2 expression. NFAT and SHP2 were needed to sustain PAH-PASMC proliferation and resistance to apoptosis. Finally, delivery of synthetic miR-204 to the lungs of animals with PAH significantly reduced disease severity. This study uncovers a new regulatory pathway involving miR-204 that is critical to the etiology of PAH and indicates that reestablishing miR-204 expression should be explored as a potential new therapy for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., Orlov, Y. L., Zhang, W., Jiang, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.043 · Cited by 2,501
Cellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
NFAT proteins: key regulators of T-cell development and function
Macian, F. (2005) · Nature Reviews Immunology · doi:10.1038/nri1632 · Cited by 1,569
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Self-citationChristman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D. J., Levy, R. D., Cernacek, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., Dean, D. B., & Zhang, C. (2007) · Circulation Research · doi:10.1161/circresaha.106.141986 · Cited by 920
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., & Waxman, A. B. (2009) · Circulation Research · doi:10.1161/circresaha.108.182014 · Cited by 655
Bonnet, S., Michelakis, E. D., Porter, C. J., Andrade-Navarro, M. A., Thébaud, B., Bonnet, S., Haromy, A., Harry, G., Moudgil, R., McMurtry, M. S., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.609008 · Cited by 590
Self-citationTransfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
Khan, A. A., Betel, D., Miller, M. L., Sander, C., Leslie, C. S., & Marks, D. S. (2009) · Nature Biotechnology · doi:10.1038/nbt.1543 · Cited by 534
Imatinib for the Treatment of Pulmonary Arterial Hypertension
Ghofrani, H. A., Seeger, W., & Grimminger, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051946 · Cited by 492
Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Montani, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1037oc · Cited by 472
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
Pathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Yu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Bonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 364
Self-citationPrimary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression
Yu, Y., Sweeney, M., Zhang, S., Platoshyn, O., Landsberg, J., Rothman, A., & Yuan, J. X.-J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00125.2002 · Cited by 337
Caruso, P., MacLean, M. R., Khanin, R., McClure, J., Soon, E., Southgate, M., MacDonald, R. A., Greig, J. A., Robertson, K. E., Masson, R., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.202028 · Cited by 336
MicroRNAs and cardiac pathology
Latronico, M. V. G., & Condorelli, G. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.56 · Cited by 324
Pathology of Pulmonary Hypertension
Tuder, R. M., Marecki, J. C., Richter, A., Fijalkowska, I., & Flores, S. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.010 · Cited by 324
Cowan, K. N., Jones, P. L., & Rabinovitch, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6539 · Cited by 302
Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells
Sakao, S., Taraseviciene‐Stewart, L., Lee, J. D., Wood, K., Cool, C. D., & Voelkel, N. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3261fje · Cited by 301
Yuan, X.-J. (1995) · Circulation Research · doi:10.1161/01.res.77.2.370 · Cited by 296
Micromarkers: miRNAs in cancer diagnosis and prognosis
Ferracin, M., Veronese, A., & Negrini, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.11 · Cited by 266
Steudel, W., Ichinose, F., Huang, P. L., Hurford, W. E., Jones, R. C., Bevan, J. A., Fishman, M. C., & Zapol, W. M. (1997) · Circulation Research · doi:10.1161/01.res.81.1.34 · Cited by 251
Endothelin receptor antagonists in pulmonary arterial hypertension
Dupuis, J., & Hoeper, M. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00078207 · Cited by 235
MicroRNA‐204/211 alters epithelial physiology
Wang, F. E., Zhang, C., Maminishkis, A., Dong, L., Zhi, C., Li, R., Zhao, J., Majerciak, V., Gaur, A. B., Chen, S., et al. (2010) · The FASEB Journal · doi:10.1096/fj.08-125856 · Cited by 230
A Histochemical and Ultrastructural Study
Springer-Verlag, H. (1983) · Cited by 218
Bourillot, P.-Y., Aksoy, I., Schreiber, V., Wianny, F., Schulz, H., Hummel, O., Hubner, N., & Savatier, P. (2009) · Stem Cells · doi:10.1002/stem.110 · Cited by 202
Rajkumar, R., Konishi, K., Richards, T. J., Ishizawar, D. C., Wiechert, A. C., Kaminski, N., & Ahmad, F. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00254.2009 · Cited by 196
Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation
Platoshyn, O., Golovina, V. A., Bailey, C. L., Limsuwan, A., Krick, S., Juhaszova, M., Seiden, J. E., Rubin, L. J., & Yuan, J. X.-J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1540 · Cited by 164
PDGF signaling in pulmonary arterial hypertension
Barst, R. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26593 · Cited by 162
Lee, Y., Yang, X. H., Huang, Y., Fan, H., Zhang, Q., Wu, Y., Li, J., Hasina, R., Cheng, C., Lingen, M. W., et al. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000730 · Cited by 155
Todorovich-Hunter, L., Johnson, D. J., Ranger, P., KEELEY, F. W., & Rabinovitch, M. (1988) · PubMed · Cited by 151
Naylor, J., Li, J., Milligan, C. J., Zeng, F., Sukumar, P., Hou, B., Sedó, A., Yuldasheva, N. Y., Majeed, Y., Beri, D., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.219329 · Cited by 144
Gharavi, N. M., Alva, J. A., Mouillesseaux, K. P., Lai, C. K., Yeh, M. W., Yeung, W., Johnson, J. P., Szeto, W. L., Hong, L., Fishbein, M. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704267200 · Cited by 142
Cutting Edge: Transcriptional Activity of NFATc1 Is Enhanced by the Pim-1 Kinase
Rainio, E.-M., Sandholm, J. A., & Koskinen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1524 · Cited by 140
An essential role for SRC-activated STAT-3 in 14,15-EET–induced VEGF expression and angiogenesis
Cheranov, S. Y., Karpurapu, M., Wang, D., Zhang, B., Venema, R. C., & Rao, G. N. (2008) · Blood · doi:10.1182/blood-2007-11-126680 · Cited by 138
Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials
Jurasz, P., Courtman, D. W., Babaie, S., & Stewart, D. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.006 · Cited by 137
Bonnet, S., Paulin, R., Sutendra, G., Dromparis, P., Roy, M., Watson, K., Nagendran, J., Haromy, A., Dyck, J. R. B., & Michelakis, E. D. (2009) · Circulation · doi:10.1161/circulationaha.109.848911 · Cited by 122
Self-citationMicroRNAs as a therapeutic target for cardiovascular diseases
Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00744.x · Cited by 119
Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src
Wong, W. K. P., Knowles, J. A., & Morse, J. H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0103oc · Cited by 104
Bonnet, S., & Archer, S. L. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.014 · Cited by 100
Self-citationMicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease
Zhang, C. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9837 · Cited by 96
An Ultraviolet-activated K+ Channel Mediates Apoptosis Of Myeloblastic Leukemia Cells
Wang, L., Xu, D., Dai, W. H., & Lu, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3678 · Cited by 95
Adaptor Protein Shc Is an Isoform-specific Direct Activator of the Tyrosine Kinase c-Src
Sato, K., Nagao, T., Kakumoto, M., Kimoto, M., Otsuki, T., Iwasaki, T., Tokmakov, A. A., Owada, K. M., & Fukami, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203179200 · Cited by 70
RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
Barman, S. A., Zhu, S., & White, R. E. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4711 · Cited by 67
Fornaro, M., Burch, P. M., Yang, W., Zhang, L., Hamilton, C., Kim, J. H., Neel, B. G., & Bennett, A. M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200602029 · Cited by 66
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH
Tada, Y., Majka, S. M., Carr, M., Harral, J. W., Crona, D. J., Kuriyama, T., & West, J. D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00305.2006 · Cited by 66
Role of Pim-1 in Smooth Muscle Cell Proliferation
Katakami, N., Kaneto, H., Hao, H., Umayahara, Y., Fujitani, Y., Sakamoto, K., Gorogawa, S.-I., Yasuda, T., Kawamori, D., Kajimoto, Y., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409140200 · Cited by 65
Regulation of RhoA-dependent ROCKII activation by Shp2
Lee, H., & Chang, Z.-F. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710187 · Cited by 62
Molecular mechanisms of pulmonary hypertension
Yildiz, P. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.018 · Cited by 60
Brégeon, J., Loirand, G., Pacaud, P., & Rolli‐Derkinderen, M. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00174.2009 · Cited by 58
Shibata, R., Kai, H., Seki, Y., Kato, S., Wada, Y., Hanakawa, Y., Hashimoto, K., Yoshimura, A., & Imaizumi, T. (2003) · Human Gene Therapy · doi:10.1089/104303403321618128 · Cited by 56
Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung
Zhao, L., Al‐Tubuly, R., Sebkhi, A., Owji, A. A., Nunez, D. J., & Wilkins, M. R. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16025.x · Cited by 49
Yellaturu, C. R., & Rao, G. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211276200 · Cited by 42
de la Roque, E. D., Savineau, J., & Bonnet, S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.003 · Cited by 39
Self-citationWu, J., Goswami, R., Cai, X., Exum, S. T., Huang, X., Zhang, L., Brian, L., Premont, R. T., Peppel, K., & Freedman, N. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605756200 · Cited by 38
Kimura, K., & Eguchi, S. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00399.2009 · Cited by 19
Li, J., Niu, X.-L., & Madamanchi, N. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806087200 · Cited by 16
Pim-1 kinase enhances NFATc activity and neuroendocrine functions in PC12 cells
Glazova, M. V., Aho, T. L. T., Palmetshofer, A., Murashov, A. K., Scheinin, M., & Koskinen, P. J. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.003 · Cited by 12
Cited by
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Lee, C., Mitsialis, S. A., Aslam, M., Vitali, S. H., Vergadi, E., Konstantinou, G., Sdrimas, K., Fernandez-Gonzalez, A., & Kourembanas, S. (2012) · Circulation · doi:10.1161/circulationaha.112.114173 · Cited by 793
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Tuder, R. M., Archer, S. L., Dorfmüller, P., Erzurum, S. C., Guignabert, C., Michelakis, E., Rabinovitch, M., Schermuly, R., Stenmark, K. R., & Morrell, N. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.025 · Cited by 585
Metadata
- Authors
- Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., Simard, M. J., & Bonnet, S.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 208
- Issue
- 3
- Pages
- 535-548
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2128940917
- Cited by
- 523
- References
- 64
- FWCI
- 39.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.